Skip to content

How SGLT-2 Inhibitor decrease Atrial Heart Muscle Damage in Rheumatic Mitral Valve Disease disease patients

Effect Of SGLT-2 Inhibitor On Indices Of Atrial Myopathy In Rheumatic Mitral Valve Disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063983
Enrollment
50
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I052- Rheumatic mitral stenosis with insufficiency

Interventions

Control Intervention1: nil: nil

Sponsors

GOVIND BALLABH PANT INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: rheumatic mitral valve disease of moderate seviarity includes moderate mitral stenosis/ moderate mitral regurgitation/ combination of both with any of the high risk features in form of 48-hour holter monitoring showing paroxysmal /non sustained atrial arrythmia. Trans thoracic echocardiography LA anteroposterior diameter more than 3.5cm. Abnormal LA strain or LAA velocity. LA or LAA smoke. History of transient ischemic attack in past.

Exclusion criteria

Exclusion criteria: Rheumatic mitral disease requiring intervention/surgery Associated congenital heart disease. Left ventricular systolic dysfunction Associated chronic kidney disease or known coronary artery disease. Pregnancy and lactation. Low quality echocardiographic image. Concomitant aortic stenosis and/or regurgitation .

Design outcomes

Primary

MeasureTime frame
To measure the decrease in P wave dispersion by SGLT-2 inhibitors in rheumatic mitral valve disease.Timepoint: 6 months

Secondary

MeasureTime frame
Change in atrial electro-mechanical coupling intervalTimepoint: 6 months;Change in LA strainTimepoint: 6 months;Change in LAA velocityTimepoint: 6 months;Change in other P wave indices PTFV1Timepoint: 6 months

Countries

India

Contacts

Public ContactAbhishek nagar

Govind Ballabh Pant Institute of Post Graduate Medical Education and Research new Delhi

jamalyusuf72@yahoo.com9718599104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026